Schumer Bill Would Prohibit Sale Of Recalled Products
This article was originally published in The Tan Sheet
Executive Summary
Ambiguities in a recently-introduced bill that would make it illegal to sell recalled products may reduce voluntary recalls by FDA-regulated companies, a food and drug attorney says.
You may also be interested in...
Abbott's Similac Recall Triggers Overflow Demand For Answers
Consumer response to Abbott Laboratories' recall of powder Similac and other infant formula products initially exceeded the firm's capabilities to handle telephone calls and support online traffic to its websites
J&J Faces Possible Criminal Liability As Post-Recall Overhaul Continues
FDA's drug center referred its review of Johnson & Johnson's manufacturing operations to the Office of Criminal Investigations, which will determine whether there is criminal liability in the quality control lapses that led to extensive recalls of OTC drugs
Coalition Pushes Congress On OTC Purchases With Health Savings Accounts
The Health Choices Coalition sent letters urging House and Senate members to support legislation that would strike the health care reform law requirement that consumers obtain a prescription in order to purchase OTCs with a pre-tax savings account.